期刊文献+

静脉药物调配中心(PIVAs)细胞毒性药物的质量控制及安全防护 被引量:22

Quality control and safety protection of cytotoxic drugs in hospital PIVAs
原文传递
导出
摘要 目的:介绍静脉药物调配中心(PIVAs)对临床安全使用细胞毒性药物的作用。方法:查阅近年来相关文献及药品说明书,同时结合医院PIVAs的实际情况,对在细胞毒性药物的质量稳定性、临床用药的合理性、医护人员的职业防护等方面进行了经验总结。结果:PIVAs的建立,对细胞毒性药物合理、安全使用具有显著性优势,同时促进了医院药学的发展。结论:PIVAs的建立为医院药学发展提供了新的机遇,加强医生、药师、护士之间的沟通与合作,促进了临床药学的发展,值得推广。 OBJECTIVE To introduce role of pharmacy intravenous admixture services(PIVAs)for safe use of cytotoxic drugs.METHODS Relevant literatures and instructions in recent years were reviewed,actual situations of our hospital PIVAs were combined.Quality and stability of cytotoxic drugs,rational clinical use of drugs,as well as protection and other aspects of occupational health care were all summarized.RESULTS PIVAs had significant advantages for reasonable and safe use of cytotoxic drugs,and could promote development of hospital pharmacy.CONCLUSION PIVAs is worth promoting.It provides new opportunities for development of hospital pharmacy,strengthens communication and cooperation between doctors,pharmacists and nurses,and promotes development of clinical pharmacy.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2015年第18期1703-1705,共3页 Chinese Journal of Hospital Pharmacy
关键词 静脉药物调配中心 细胞毒性药物 合理用药 临床药学 pharmacy intravenous admixture service (PIVAs) eytotoxic drugs rational drug use clinical pharmacy
  • 相关文献

参考文献4

二级参考文献35

  • 1吕伟伟,董玉波,孙成春,孙军.利用PASS系统监测医嘱用药[J].中国药房,2005,16(22):1708-1709. 被引量:28
  • 2刘学理,李东,何伶.医院静脉药物集中配置中心的建设与意义[J].医药导报,2005,24(12):1195-1196. 被引量:20
  • 3王宏.抗菌药物PK/PD参数与临床给药方案分析[J].中国药师,2006,9(9):854-856. 被引量:12
  • 4韩钢,方红梅,章辉.我院静脉药物配置中心开展的临床药学工作[J].中华医院管理杂志,2006,22(12):815-816. 被引量:17
  • 5Turci R,Sottani C,Spagnoli G,et al.Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents:a review of analytical methods.J Chromatogr B Analyt Technol Biomed Life Sci,2003,789:169-209.
  • 6Sessink PJ,Wittenhorst BC,Anzion RB,et al.Exposure of pharmacy technicians to antineoplastic agents:reevaluation after additional protective measures.Arch Environ Health,1997,52:240-244.
  • 7Connor TH.Shults M.Fraser MP.Determination of the vaporization of solutions of mutagenic antineoplastic agents at 23 and 37 degrees C using a desiccator technique.Mutat Res,2000,470:85-92.
  • 8Sessink PJ,Timmersmans JL,Anzion RB,et al.Assessment of occupational exposure of pharmaceutical plant workers to 5-fluorouracil.Deptermination of alpha-fluoro-beta-alanine in urine.J Occup Mcd,1994,36:79-83.
  • 9Spivey S,Connor TH.Determining source of workplace contamination with antineoplastic drogs and comparing conventional Ⅳ drug preparation with a closed system.Hosp Pharm,2003,38:135-139.
  • 10Stoikes ME,Carlson JD.Farris FF,et al.Permeability of latex and polyvinyl chloride gloves to fluorouracil and methotrexate.Am J Hosp Pharm,1987,44:1341-1346.

共引文献57

同被引文献183

引证文献22

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部